-+ 0.00%
-+ 0.00%
-+ 0.00%

Viking Therapeutics Q1 GAAP EPS $(0.41) Misses $(0.34) Estimate

Benzinga·04/23/2025 20:10:12
Listen to the news
Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.34) by 20.59 percent. This is a 57.69 percent decrease over losses of $(0.26) per share from the same period last year.